Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria

被引:11
|
作者
Zimmerman, Tahl [1 ]
Carlos Lacal, Juan [2 ]
Ibrahim, Salam A. [1 ]
机构
[1] North Carolina Agr & Tech State Univ, Food & Nutr Sci Program, Food Microbiol & Biotechnol Lab, Greensboro, NC 27401 USA
[2] Hosp Univ Fuenlabrada, Dept Oncol, Madrid, Spain
来源
FRONTIERS IN MICROBIOLOGY | 2019年 / 10卷
关键词
choline kinase; antimicobial; antibiotic; gram-positive; Streptococcus pneumoniae; STREPTOCOCCUS-PNEUMONIAE; THERAPEUTIC TARGET; LIPOTEICHOIC ACID; BINDING-PROTEINS; CELL-WALL; ALPHA; PHOSPHORYLCHOLINE; INHIBITION; EXPRESSION; RSM-932A;
D O I
10.3389/fmicb.2019.02146
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Both nosocomial pathogens, such as Streptococcus pneumoniae and Haemophilus influenzae and food-borne pathogens, such as Bacillus cereus and Clostridium perfringens are known to be detrimental to human and animal health. The effectiveness of currently used treatments for these pathogens becomes limited as resistant strains emerge. Therefore, new methods for eliminating bacterial pathogens must be developed continuously. This includes establishing novel targets to which drug discovery efforts could be focused. A promising method for discovering new drug targets in prokaryotes is to take advantage of the information available regarding the enzymatic pathways that have been established as drug targets in eukaryotic systems and explore the analogous pathways found in bacterial systems. This is an efficient strategy because the same inhibitors developed at considerable expense to block these pathways in eukaryotic systems could also be employed in prokaryotes. Drugs that are used to prevent diseases involving eukaryotic cells could be repurposed as antibiotics and antimicrobials for the control of bacteria pathogens. This strategy could be pursued whenever the primary and tertiary structures of a target are are conserved between eukaryotic and prokaryotes. A possible novel target fitting these parameters is choline kinase (ChoK), whose active site sequences are conserved (Figure 1) and whose tertiary structure (Figure 2) is maintained. Here, we describe why ChoK is a putative drug target by describing its role in the growth and pathogenesis of Gram-positive bacteria S. pneumoniae and the Gram-negative bacteria H. influenzae. Using S. pneumoniae as a model, we also present promising preliminary information that repurposing of drugs known to inhibit the human isoform of ChoK (hChoK), is a promising strategy for blocking the growth of S. pneumoniae cells and inhibiting the activity of the S. pneumoniae isoform of ChoK (sChok), with downstream physiological effects on the cell wall.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Antimicrobial Resistance in Gram-Positive Bacteria
    Buke, Cagri
    KLIMIK JOURNAL, 2010, 23 (02) : 34 - 34
  • [32] PNEUMONIAE DUE TO GRAM-POSITIVE BACTERIA
    DELSOLAR, A
    GODOY, P
    REVISTA MEDICA DE CHILE, 1981, 109 (11) : 1115 - 1118
  • [33] ON THE RELEVANCE OF GRAM-POSITIVE BACTERIA IN PROSTATITIS
    BERGMAN, B
    INFECTION, 1994, 22 : S22 - S22
  • [34] NEW QUINOLONES AND GRAM-POSITIVE BACTERIA
    PIDDOCK, LJV
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) : 163 - 169
  • [35] Envelope Structures of Gram-Positive Bacteria
    Rajagopal, Mithila
    Walker, Suzanne
    PROTEIN AND SUGAR EXPORT AND ASSEMBLY IN GRAM-POSITIVE BACTERIA, 2017, 404 : 1 - 44
  • [36] Multiply resistant Gram-positive bacteria
    不详
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 31 - 36
  • [37] Selenoproteins in Archaea and Gram-positive bacteria
    Stock, Tilmann
    Rother, Michael
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (11): : 1520 - 1532
  • [38] Phage Adsorption to Gram-Positive Bacteria
    Leprince, Audrey
    Mahillon, Jacques
    VIRUSES-BASEL, 2023, 15 (01):
  • [39] Sortase enzymes in Gram-positive bacteria
    Spirig, Thomas
    Weiner, Ethan M.
    Clubb, Robert T.
    MOLECULAR MICROBIOLOGY, 2011, 82 (05) : 1044 - 1059
  • [40] MEMBRANE TRANSITIONS IN GRAM-POSITIVE BACTERIA
    ASHE, GB
    STEIM, JM
    BIOCHIMICA ET BIOPHYSICA ACTA, 1971, 233 (03) : 810 - &